Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022

Mark K. Weng; Mona Doshani; Mohammed A. Khan; Sharon Frey; Kevin Ault; Kelly L. Moore; Eric W. Hall; Rebecca L. Morgan; Doug Campos-Outcalt; Carolyn Wester; Noele P. Nelson

doi:10.15585/MMWR.MM7113A1

Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022

Mark K. Weng, Mona Doshani, Mohammed A. Khan, Sharon Frey, Kevin Ault, Kelly L. Moore, Eric W. Hall, Rebecca L. Morgan, Doug Campos-Outcalt, Carolyn Wester, Noele P. Nelson

School Of Public Health

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Abstract

Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in the United States. This Advisory Committee on Immunization Practices (ACIP) recommendation expands the indicated age range for universal HepB vaccination to now include adults aged 19-59 years. Removing the risk factor assessment previously recommended to determine vaccine eligibility in this adult age group (2) could increase vaccination coverage and decrease hepatitis B cases.

Original language	English (US)
Pages (from-to)	477-483
Number of pages	7
Journal	Morbidity and Mortality Weekly Report
Volume	71
Issue number	13
DOIs	https://doi.org/10.15585/MMWR.MM7113A1
State	Published - 2022

ASJC Scopus subject areas

Epidemiology
Health(social science)
Health, Toxicology and Mutagenesis
Health Information Management

Access to Document

10.15585/MMWR.MM7113A1

Cite this

Weng, M. K., Doshani, M., Khan, M. A., Frey, S., Ault, K., Moore, K. L., Hall, E. W., Morgan, R. L., Campos-Outcalt, D., Wester, C., & Nelson, N. P. (2022). Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. Morbidity and Mortality Weekly Report, 71(13), 477-483. https://doi.org/10.15585/MMWR.MM7113A1

Weng, MK, Doshani, M, Khan, MA, Frey, S, Ault, K, Moore, KL, Hall, EW, Morgan, RL, Campos-Outcalt, D, Wester, C & Nelson, NP 2022, 'Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022', Morbidity and Mortality Weekly Report, vol. 71, no. 13, pp. 477-483. https://doi.org/10.15585/MMWR.MM7113A1

@article{c722cdf86d354281a662bc8cbae06c09,

title = "Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022",

abstract = "Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in the United States. This Advisory Committee on Immunization Practices (ACIP) recommendation expands the indicated age range for universal HepB vaccination to now include adults aged 19-59 years. Removing the risk factor assessment previously recommended to determine vaccine eligibility in this adult age group (2) could increase vaccination coverage and decrease hepatitis B cases.",

author = "Weng, {Mark K.} and Mona Doshani and Khan, {Mohammed A.} and Sharon Frey and Kevin Ault and Moore, {Kelly L.} and Hall, {Eric W.} and Morgan, {Rebecca L.} and Doug Campos-Outcalt and Carolyn Wester and Nelson, {Noele P.}",

year = "2022",

doi = "10.15585/MMWR.MM7113A1",

language = "English (US)",

volume = "71",

pages = "477--483",

journal = "Morbidity and Mortality Weekly Report",

issn = "0149-2195",

publisher = "Department of Health and Human Services",

number = "13",

}

TY - JOUR

T1 - Universal Hepatitis B Vaccination in Adults Aged 19-59 Years

T2 - Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022

AU - Weng, Mark K.

AU - Doshani, Mona

AU - Khan, Mohammed A.

AU - Frey, Sharon

AU - Ault, Kevin

AU - Moore, Kelly L.

AU - Hall, Eric W.

AU - Morgan, Rebecca L.

AU - Campos-Outcalt, Doug

AU - Wester, Carolyn

AU - Nelson, Noele P.

PY - 2022

Y1 - 2022

N2 - Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in the United States. This Advisory Committee on Immunization Practices (ACIP) recommendation expands the indicated age range for universal HepB vaccination to now include adults aged 19-59 years. Removing the risk factor assessment previously recommended to determine vaccine eligibility in this adult age group (2) could increase vaccination coverage and decrease hepatitis B cases.

AB - Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in the United States. This Advisory Committee on Immunization Practices (ACIP) recommendation expands the indicated age range for universal HepB vaccination to now include adults aged 19-59 years. Removing the risk factor assessment previously recommended to determine vaccine eligibility in this adult age group (2) could increase vaccination coverage and decrease hepatitis B cases.

UR - http://www.scopus.com/inward/record.url?scp=85127423375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127423375&partnerID=8YFLogxK

U2 - 10.15585/MMWR.MM7113A1

DO - 10.15585/MMWR.MM7113A1

M3 - Article

C2 - 35358162

AN - SCOPUS:85127423375

SN - 0149-2195

VL - 71

SP - 477

EP - 483

JO - Morbidity and Mortality Weekly Report

JF - Morbidity and Mortality Weekly Report

IS - 13

ER -

Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this